A rare case of erythema dyschromicum perstans arising in the setting of a third-generation tyrosine kinase inhibitor.
Acta Oncol
; 61(7): 830-832, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35658740
Full text:
1
Database:
MEDLINE
Main subject:
Skin Diseases, Genetic
/
Erythema
Limits:
Humans
Language:
En
Journal:
Acta Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
United States